FARMINGDALE, N.Y., May 5, 2011 /PRNewswire/ — Misonix, Inc.
(NASDAQ:
MSON), a medical device company that designs, manufactures, and
markets innovative therapeutic ultrasonic products worldwide for
wound debridement, cosmetic surgery, neurosurgery, laparoscopic
surgery, and other surgical and medical applications, today
announced plans to release third quarter ended March 31, 2011
financial results on Tuesday, May 10, 2011. Michael A.
McManus, President and Chief Executive Officer and Richard Zaremba,
Senior VP and Chief Financial Officer, will host a conference call
at 11:30 a.m. Eastern on Tuesday, May 10, 2011 to discuss the
Company’s third quarter 2011 financial results.
Shareholders and other interested parties may participate in the
conference call by dialing (800) 561-2601 (domestic) or (617)
614-3518 (international) and entering access code 51509337, a few
minutes before the start of the call. A simultaneous webcast will
be available via Misonix’s website at www.misonix.com.
The call will be archived on the Company’s website for at least 90
days.
A recording of the live-call will be available approximately 2
hours after the event through May 17, 2011. The dial-in number to
listen to the recording is (888) 286-8010 or (617) 801-6888. The
replay access code is 66431203.
About Misonix:
Misonix, Inc. (NASDAQ:
MSON) designs, develops, manufactures and markets therapeutic
ultrasonic medical devices. Misonix’s therapeutic ultrasonic
platform is the basis for several innovative medical technologies.
Addressing a combined market estimated to be in excess of $3
billion annually; Misonix’s proprietary ultrasonic medical devices
are used for spine surgery, wound debridement, cosmetic surgery,
neurosurgery, laparosco
‘/>”/>
SOURCE
